Reactions to Antituberculous Drugs and Desensitization Treatment
Author:
Publisher
Springer Science and Business Media LLC
Subject
Medicine (miscellaneous),Immunology and Allergy
Link
http://link.springer.com/content/pdf/10.1007/s40521-019-00208-z.pdf
Reference60 articles.
1. Connell DW, Berry M, Cooke G, Kon OM. Update on tuberculosis: TB in the early 21st century. Eur Respir Rev. 2011;20:71–84. https://doi.org/10.1183/09059180.00000511 . This is a review paper of most relevance because it updates on important developments in TB diagnostics, in both latent infection and active disease, briefly discuss TB/HIV and review advances in the treatment of TB, including the management of drug-resistant disease.
2. Mack U, Migliori GB, Sester M, Rieder HL, Ehlers S, Goletti D, et al. Eur Respir J. 2009;33:956–73. https://doi.org/10.1183/09031936.00120908 .
3. C Dye S, Scheele P, Dolin V, Pathania MC. Raviglione. Consensus statement. Global burden of tuberculosis: estimated incidence, prevalence, and mortality by country. WHO Global Surveillance and Monitoring Project. JAMA. 1999;282(7):677–86. https://doi.org/10.1001/jama.282.7.677 .
4. Aouam K, Chaabane A, Loussaïef C, Ben Romdhane F, Boughattas NA, Chakroun M. Adverse effects of antitubercular drugs: epidemiology, mechanisms, and patient management. Med Mal Infect. 2007;37:253–61. https://doi.org/10.1016/j.medmal.2006.12.006 . It is intended to the knowledge of current therapeutic regimens with isoniazid, rifampicin, pyrazinamide, ethambutol, and streptomycin in treating tuberculosis . These drugs are associated to a high rate of adverse effects. The understanding of the nature and the severity of these adverse effects allows for their appropriate management.
5. Combs DL, O’brien RJ, Geiter LJ. USPHS tuberculosis short-course chemotherapy trial 21: effectiveness, toxicity, and acceptability. Ann Intern Med. 1990;112:397. https://doi.org/10.7326/0003-4819-76-3-112-6-397 .
Cited by 2 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Anaphylactic Shock After First-Line Treatment With Antituberculosis Drugs in a Patient With Lupus;Cureus;2023-05-11
2. Practical management of suspected hypersensitivity reactions to anti‐tuberculosis drugs;Clinical & Experimental Allergy;2022-01-20
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3